Developmental pharmacology and toxicology: Biotransformation of drugs and other xenobiotics during postnatal development

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 30, Issue 1-2, 2005, Pages 3-17

  Klinger, Wolfgang ^a,b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Anxiolytic agent; Human hepatic S9; In vitro metabolism; Metabolite identification; RWJ 51521

Indexed keywords

1 NAPHTHOL; 2 AMINOPHENOL; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 3 METHYLCHOLANTHRENE; ALCOHOL; BILIRUBIN; CYTOCHROME P450 ISOENZYME; GLUCOCORTICOID; GLUCURONOSYLTRANSFERASE; ISOENZYME; MORPHINE; PHENOBARBITAL; PHENOLPHTHALEIN; SEROTONIN; STEROID; TESTOSTERONE; XENOBIOTIC AGENT;

AGE DISTRIBUTION; AGING; DRUG DISPOSITION; DRUG METABOLISM; DRUG TRANSFORMATION; EMBRYOTOXICITY; ENZYME INDUCTION; ENZYME MECHANISM; ENZYME SYNTHESIS; GENETIC HETEROGENEITY; GENETIC REGULATION; GENETIC TRANSCRIPTION; NONHUMAN; ONTOGENY; PHARMACODYNAMICS; POSTNATAL DEVELOPMENT; PREGNANCY; REVIEW; SPECIES DIFFERENCE; TOXICOKINETICS; TOXICOLOGICAL PARAMETERS;

EID: 21344466542     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03226403     Document Type: Review

References (91)

1. Ackermann E, Heinrich I (1970) Die Aktivität der N- und O-Demethylase in der Leber des Menschen (The activity of the N- and O-demethylase in the liver of the human being). Biochem. Pharmacol. 19, 327-342
2. Ackermann E, Rane A (1971) The monooxygenase system in the human fetal liver: subcellular distribution and studies on in vitro metabolism of aniline. Chem-Biol. Interactions 3, 233-234
3. Ankermann H, Klinger W, Möller A (1965) Hexobarbital narcosis and age. Acta biol. med. german. 14, 496-503
4. Ankermann H, Traeger A (eds.) 1972 Beiträge zur Entwicklungspharmakologie. Friedrich-Schiller-Universität 1972
5. Ankermann H (ed) (1973) Entwicklungspharmakologie (Developmental Pharmacology). VEB Verlag Volk und Gesundheit Berlin
6. Astrachanzewa LZ (1972) Geratric Pharmacology (in Russian). German translation by Klinger W (1977). Publ. House Medicine, Leningrad, VEB Verlag Volk und Gesundheit Berlin
7. Atlas S A, Boobis A R, Feiton J S, Thorgeirsson S S, Neben DW (1977) Ontogenetic expression of polycyclic aromatic compounds inducible monooxygenases activities and forms of cytochrome P-450 in rabbit. Evidence for temporal control and organ specificity of two genetic regulatory systems. J. Biol. Chem. 252, 4712-4721
8. Axelrod J (1960) Biochemical factors in the activation and inactivation of drugs. Arch. exp. Path. Pharm. 238, 24-35
9. Barth A, Klinger W, Hoppe H (1986) Hepatic elimination kinetics od organic anions in rats:developmental aspects and influence of phenobarbital. Arch. Int. Pharmacodyn. Ther. 283:16-29
10. Basu TK, Dickerson JWT, Parke DVW (1971) Effect of development on the activity of microsomal drug metabolizing enzymes in rat liver. Biochem. J. 124, 19-24
11. Birnbaum LS, Baird MB (1979) Senescent changes in rodent hepatic epoxide metabolism. Chem. Biol, Interact. 26:254-256
12. Brandt IK (1964) The development of the hippuric acid-synthesizing system in the rat. Develop. Biol. 10, 202-215
13. Burchell B, Nebert DW, Nelson DR, Bock KW, Iyanagi T, Jansen PLM, Lancet D, Mulder GJ, Chowdhury JR, Siest G, Tephly TR, Mackenzie PI (1991) The UDP glucuronosyl-transferase gene superfamily: suggested nomenclature based on evolutionary divergence. DNA and Cell Biol. 10, 487-494
14. Carrol J (1969) Phenosulfotransferase in the developing rat. Am. J. Clin. Nutr. 22:978-985
15. Combes B, Stakelum GS (1961) Maturation of liver enzyme that conjugates sulfobromophtalein sodium (BSP) and glutathione. J. Clin. Invest. 40:1030-1031
16. David H (1985) The Hepatocyte, Development, Differentiation, and Aging. VEB Gustav Fischer Jena
17. Done AK (1964) Developmental pharmacology. Clin. Pharmacol. Ther. 5, 432-479
18. Done AK (1966) Perinatal pharmacology. Ann. Rev. Pharmacol. 6, 189-208
19. Delpech I, Kiffel L, Magdalou J, Andre JC, Siest G (1982) 8th Europ. Workshop on Drug Metab., Sart Tilman, Belgium, Spt. 5-9, No. 41
20. Dutton GJ (1966) Variations in the glucuronide formation by perinatal liver. Biochem. Pharmacol. 15, 947-951
21. Dutton GJ, Lawes J (1966) Multiplicity of liver uridine 5-pyrophosphate glucuronyltrans-ferase from ist varying pattern of development with different substrates and species. Biochem. J. 98, 30p
22. Guenthner TM, Nebert DW (1978) Evidence in rat and mouseliver for temporal control of two polycyclic aromatic inducible forms of cytochrome P-450. Eur. J. Biochem. 91:449-456
23. Fouts JR, Adamson RH (1959) Drug metabolism in the newborn rabbit. Science 129, 897-898
24. Fouts JR (1961) Physiological impairment of drug metabolism. Proc. 1st Internat. Pharmacol. Meeting Stockholm. Vol. 6:257-271
25. Haeckel E (1866) Generelle Morphologie der Organismen, Bd. II: Allgemeine Entwicklungsgeschichte der Orgnismen. Berlin, S. 300
26. Häßler A (1969) The influence of breeding conditions on individual varation of drug effect in rats of different ages (in German). Thesis Medical Faculty, Friedrich-Schiller-University Jena
27. Holmes RS, Masters CJ (1967) The developmental multiplicity and isoenzyme status of rat esterases. Biochim. Biophys. Acta 146: 138-150
28. Hüller H, Jährig K, Göretzlehner G, Traeger A (eds) (1987) Arzneimittelanwendung in Schwangerschaft und Stillperiode (Drugs in Pregnancy and Nursing Period). VEB Verlag Volk und Gesundheit Berlin 1987.
29. Jahn F, Klinger W. (1989) Influence of prenatal administration of cadmium on postnatal development and inducibility of hepatic monooxygenases in rats. Phamacol. Toxicol. 64:292-292
30. Jondorf WR, Maickel RT, Brodie BB (1958) Inability of newborn mice and guinea pigs to metabolize drugs. Biochem. Pharmacol. 1, 352-354
31. Kahl GF, Friederici DE, Bigelow SW, Okexy AB, Nebert DW (1980) Ontogenetic expression of regulatory and structural gene products associated with the Ah-locus. Devel. Pharmac. Ther. 1:137-162
32. Karunairatnam MC, Kerr LM, Levvy GA (1949) The glucuronide-synthesizing system in the mouse and ist relationship to β-glucuronidase. Biochem. J. 45, 496
33. Kato R, Vassanelli P, Frontino G, Chiesara E (1964) Variation in the activity of liver microsomal drug metabolizing enzymes in rats in relation to the age. Biochem. Pharmacol. 13, 1037-1051
34. Kimmel CA, Buelke-Sam J (eds) (1981) Developmental Toxicology, Raven Press New York 1981
35. Kleeberg U, Grohmann G, Volkmann R, Steinen H, Klinger W (1979) In vivo and in vitro inhibition of 3-methylcholanthrene-induced aryl hydrocarbon hydroxylase activity in rat liver by actionomycin D and 7,8-benzoflavone. Pol. J. Phamac. Pharm. 31:675-681
36. Kleeberg U, Sommer M, Klinger W (1985) Increased response of cytochrome P450 dependent biotransformation reactions in rat liver to repeated administration of inducers. Arch. Toxicol. Suppl. 8:361-365
37. Kleeberg U (1987) Induktion Cytochrom P-450-abhängiger Biotransformationsreaktionen durch 3-Methylcholanthren. Mechanismen und poostnatale Entwicklung. Thesis, University Jena
38. Klinger W, Ankermann H (1965) The concentration of L-ascorbic acid in the organs of rats of various age and sex upon treatment with barbital. Actabiol. med. german., 14, 764-773 (1965)
39. Klinger W, Kramer B (1965) Untersuchungen zum Mechanismus der Enzyminduktion bei Ratten und Mäusen. VI. Der Einfluß des Lebensalters auf die L-Askorbinsäure-Normausscheidung und ihre Steigerung sowie auf die Hexobarbitalschlafzeit und ihre Verkürzung durch Barbital. Acta biol. med. german. 15, 7707-711
40. Klinger W, Ankermann H (1966) Die Hexobarbitalnarkose bei infantilen Ratten. Acta biol. med. germ. 17:357-359
41. Klinger W, Kusch T, Neugebauer A, Splinter FK, Ankermann H (1968) Untersuchungen zum Mechanismus der Enzyminduktion. XIV. Der Einfluss des Lebensalters auf die Aktivität und Induzierbarkeit der Phenazon-Hydrolase, Aminophenazon-N-Demethylase, Kodein-O-Demeth-ylase und Nitro-Reduktase der Rattenleber. Acta biol. med. germ. 21:257-269
42. Klinger W, Müller D. (1976) Developmental aspects of xenobiotics transformation. Environm. Health Perspect. 18:13-23
43. Klinger W, Müller D, (1977) Ethylmorphine N-demethylation by liver homogenate of newborn and adult rats; enzyme kinetics and age course of Vmax and Km. Acta biol. med. germ. 36:1149-1159
44. Klinger W, Müller D, Kleeberg U (1979) Induction and its depencence on development, In: Estabrook RW, Lindenlaub E (eds) The Induction of Drug Metabolism. Symp. Med. Hoechst 14, Schattauer Stuttgart New York, pp. 517-544
45. Klinger W (1982) Biotransformation of drugs and other xenobiotics during postnatal development. Pharmac. Ther. 16:377-429
46. Klinger W (1983) Pharmacology of the developing digestive system. Pharmac. Ther. 22, 41-51
47. Klinger W, Müller D, Danz M, Kob D, Madry M (1983) Influence of impairment of the immune system on hepatic biotransformation reaction, their postnatal development and inducibility. Exp. Pathol. 24:219-225
48. Klinger W, Jahn F (1985) Epigenetic imprinting of drug metabolism. In: Magyar T, Scuts T, Vereczky L (eds) Proc 4th Congr Hung Pharmacol Soc Budapest 1985. vol 2 Sect 4. Pergamon Oxford/Akademiai Kiado Budapest 1985, pp 384-397
49. Klinger W (1987) Developmental Aspects of Enzyme Induction and Inhibition. Pharmac. Ther. 33:55-61
50. Klinger W, Karge E (1987) Interaction of induction, ontogenetic development and liver regeneration on the monooxygenase level. Exp. Pathol. 31:117-124
51. Klinger W, Müller D, Kleeberg U, Jahn F, Glöckner R (1987) Developmental Pharmacology, In: Pharmacology, Proceedings of the Xth International Congress of Pharmacology (IUPH AR), Sydney, 23-28 August 1987, Excerpta medica Amsterdam New York Oxford, pp 753-763
52. Klinger W (1990) Biotransformation of Xenobiotics During Ontogenetic Development, In: Ruckpaul K and Rein H (eds): Frontiers in Biotransformation vol 2, Akademie-Verlag Berlin, pp 113-149
53. Klinger W (1995) Developmental regulation of biotransformation of drugs and other xenobiotics. In: Arinc E, Schenkman JB, Hodgson E (eds): Molecular Aspects of Oxidative Drug Metabolizing Enzymes. NATO ASI Series Vol. H 90, 237-248
54. Klinger W (1996) Biotransformation of drugs and other xenobiotics during postnatal development. Exp. Toxic. Path. 48, Suppl. I, 1-88
55. Koch M, Klinger W (1963) Die Beeinflussung des Ascorbinsäure- Stoffwechsels durch verschiedene Pharmaka bei Ratten. Acta biol.med.germ. 1o, 561-571, 1963
56. v. Kreybig T (1965) Experimentelle Pränatal-Toxikologie (Experimental Prenatal Toxicology) Editio Cantor KG, Aulendorf i. Württ.
57. Kuo CH, Hook JB (1980) Postnatal development of renal and hepatic drug-metabolizing enzymes in male and female Fischer 344 rats. Life Sci. 27:2433-2438
58. Lenz W, Knapp K (1962) Die Thalidomid-Embryopathie (Thalidomide Embryopathy). Dtsch. med. Wschr. 87. 1232
59. Levi AJ, Gatmaitan Z, Arias IM (1968) Two cytoplasmic proteins from rat liver and their role in hepatic uptake of sulfobromophthalein (BSP) and bilirubin. J. clin. Invest. 47, 61a
60. Levi AJ, Gatmaitan Z, Arias IM ibid. (1969) Deficiency of hepatic organic anion-binding proptein as a possible cause of non-haemolytic unconjugated hyperbilirubinaemia in the newborn. Lancet II, 139-140
61. Levi AJ, Gatmaitan Z, Arias IM ibid. (1970) Deficiency of hepatic organic anion-binding protein, impaired organic anion uptake by liver and "physiologic" jaundice in newborn monkeys. New Engl. J. Med. 283, 1136-1139
62. Lum PY, Walker S, Ioannides C (1985) Foetal and neonatal development of cytochrome P-450 and cytochrome P-448 catalyzed mixed function oxidases in the rat: Induction by 3-methylcholanthrene. Toxicol. 35:307-317
63. MacLeod SM, Okey AB, Spielberg SP (eds) (1983) Developmental Pharmacology. Alan R. Liss, Inc. New York 1983
64. Mirkin BL (1970) Developmental pharmacology. Ann. rev. Pharmacol 10, 255-272
65. Mukhtar H, Bresnick E (1976) Glutathione-S-epoxide transferase activity during development and the effect of partial hepatectomy. Cancer Res. 36:937-940
66. Müller D, Reichenbach F, Klinger W (1971) Die Aktivität der Nitroreduktase und deren Induzierbarkeit durch Barbital in der Leber von Ratten verschiedenen Alters. Acta biol. med. germ. 27:605-609
67. Müller, D, Greiling K, Greiling H, Klinger W (1983) The influence of triiodothyronine (T3) on the postnatal development of drug metabolism in rat liver. Biomed. Biochim. Acta 42:981-987
68. Nebert DW (1979) Genetic aspects of enzyme induction by drugs and chemical carcinogens, in: The Induction of Drug Metabolism, Estabrook RW, Lindenlaub E (eds), Symp. Med. Hoechst 14, Schattauer Stuttgart New York, pp 419-452
69. Nebert DW, Adesnik M, Coon MJ, Estabrook RW, Gonzalez FJ, Guengerich FP, Gunsalus IC, Johnson EF, Kemper B, Levin W, Phillips IR, Sato R, Waterman MR (1987) The P450 gene superfamily: Recommended Nomenclature. DNA 6:1-11
70. Nebert DW, Mckinnon RA (1994) Cytochrome P450: Evolution and functional diversity. Prog. Liver Dis. 12:63-97
71. Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC, Nebert DW (1996) P450 superfamily: update on new sequences, gene mapping, accision numbers and nomenclature. Pharmacogenetics 6:1-42
72. Pelkonen O, Vorne M, Arvela P, Jouppila P, Kärki NT (1971) Drug metabolizing enzymes in human fetal liver and placenta in early pregnancy. Scand. J. Clin. Lab. Invest. 27, Suppl. I16, 7
73. Pelkonen O (1980) Biotransformation of xenobiotics in the fetus. Pharmac. Ther. 10:261-281
74. Remmer H (1963) Naunyn-Schmiedeberg_s Arch. exp. Pathol. Pharmakol. 244, 311-
75. Schmucker DL (1985) Aging and drug disposition. Pharmacol. Rev. 37:133-148
76. Short CR, Davies LE (1970) Perinatal development of drug metabolizing enzyme activity in swine. J. Pharmacol. exp. Ther. 174, 185-196
77. Soyka LF, Gyermek L, Campbel P (1970) A study of the mechanism responsible for the sensitivity of newborn rats to pregnanolone. J. Pharmac. exp. Ther. 175:276-282
78. Spielmann H, Steinhoff R, Schaefer Ch, Bunjes R (1997) Arzneiverordnung in Schwangerschaft und Stillzeit. Gustav Fischer Verlag Stuttgart - Jena.
79. Strange RC, Howie AF, Hume R, Matharoo B, Bell J, Hiley C, Jones P, Beckett GJ (1989) The developmental expression of alpha-, mu- and pi-class glutathione S-transferases in human liver. Biochim. Biophys. Acta 993:186-190
80. Sutherland JM (1959) Fatal cardiovascular collapse of infants receiving large amounts of chloramphenicol. A.M.A.J.Dis. Child. 97:761-767
81. Szorady I (1982) Developmental Pharmacology. Trends Pharmacol. Sci. 3:142-144
82. Uehleke H (1964) Age dependent N-hydroxylation of aromatic amines andtoxicity. Proc. Europ. Soc. Study Drug tox. 4:140-144
83. Vasiliou V, Weiner H, Marselos M, Neben DW (1995) Mammalian aldehyde dehydrogenase genes: Classification based on evolution, structure and regulation. Europ. J. Drug Metab. Pharmacokinetics Spec. Issue 53-64
84. Vogel-Bindel U, Bentley P, Oesch F (1982) Ontogenesis, induction, inhibition, tissue distribution, immunological behaviour and purification of microsomal epoxide hydrolase with 16a, 17a-epoxyandrostene-3-one as substrate. Eur. Biochem. 126:425-431
85. Wishart GJ (1978) Functional heterogeneity of UDP-glucuronosyltransferase as indicated by its differential development and inducibility by glucocorticods. Demonstration of two groups within the enzyme_s activity towards twelve substrates. Biochem. J. 114:485-489
86. Woods JS, Dixon RL (1970) Neonatal differences in the induction of hepatic aminolevulinic acid synthetase. Biochem. Pharmacol. 19:1951-1954
87. Woods JS (1976) Developmental aspects of hepatic heme biosynthetic capability and hematotoxicity. Biochem. Pharmacol. 25:2147-2152
88. Yaffe SJ, Rane A, Sjöqvist F, Boreus LO, Orrenius S (1970) The presence of a monooxygenase system in human fetal liver microsomes. Life Sci 9, II, 1189-1200
89. Fleck C, Klinger W (eds): Proc. of the 15th European Workshop on Drug Metabolism, Jena, Sept. 9-13, 1996, Exp. Toxic Path. 48, Suppl. II, 1-436, 1996
90. Fleck C, Klinger W, Müller D (eds.): Renal and Hepatic Transport - Similarities and Differences. Proc. of an European Symposium in Halle October 6-7, 1997, Nova Acta Leopoldina NF 78, Nr. 306, 1998
91. Fleck C, Klinger W, Muller D (eds.): Molecular Investigation of Metabolism and Transport of Drugs - From Animal to Human Tissue. Proc. of an European Symposium Halle September 27-29, 2001, Nova Acta Leopoldina NF 87, Nr. 329, 2003